PMID- 34498112
OWN - NLM
STAT- MEDLINE
DCOM- 20211018
LR  - 20220218
IS  - 1437-160X (Electronic)
IS  - 0172-8172 (Print)
IS  - 0172-8172 (Linking)
VI  - 41
IP  - 11
DP  - 2021 Nov
TI  - A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 
      vaccinations among rheumatologists in Germany.
PG  - 1949-1956
LID - 10.1007/s00296-021-04986-1 [doi]
AB  - The objective is to evaluate the attitude of rheumatologists regarding the use of 
      COVID-19 vaccination in patients with inflammatory rheumatic diseases (IRDs). 
      From February 2nd until March 15th, 2021, rheumatologists from Germany were asked 
      to participate anonymously in a survey addressing their attitude with respect to 
      COVID-19 vaccinations of IRD patients. The survey was completed by 214 
      participants (107 men, 103 women, 4 unspecified). More than half of the 
      physicians (61%) were working in rheumatologic private practices and 62% had more 
      than 20 years of experience in rheumatology. 90% reported to be at least 
      confidential in handling issues of COVID-19 vaccination and 99% would recommend 
      COVID-19 vaccination for IRD patients. The majority would not recommend to stop 
      or reduce immunomodulatory drugs for vaccination except for rituximab. More than 
      70% would prefer vaccination with a mRNA vaccine for their IRD patients. This 
      study shows that almost all rheumatologists in Germany support the COVID-19 
      vaccination for their IRD patients without reducing or terminating the actual 
      immunomodulatory medication to potentially improve the response to the vaccine. 
      This attitude is in accordance with the current recommendations of the German 
      Society of Rheumatology regarding COVID-19 vaccination in IRD patients, and 
      indicates that these have been well accepted and work in everyday clinical 
      practice.
CI  - (c) 2021. The Author(s).
FAU - Hasseli, Rebecca
AU  - Hasseli R
AUID- ORCID: 0000-0002-2982-8253
AD  - Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, 
      Justus-Liebig-University Giessen, Bad Nauheim, Germany. 
      r.hasseli@kerckhoff-klinik.de.
FAU - Pfeil, Alexander
AU  - Pfeil A
AUID- ORCID: 0000-0002-2709-6685
AD  - Department of Internal Medicine III, University Hospital Jena, Jena, Germany.
FAU - Krause, Andreas
AU  - Krause A
AD  - Department of Rheumatology, Clinical Immunology and Osteology, Immanuel Hospital, 
      Berlin, Germany.
FAU - Schulze-Koops, Hendrik
AU  - Schulze-Koops H
AUID- ORCID: 0000-0002-1681-491X
AD  - Division of Rheumatology and Clinical Immunology, Department of Internal Medicine 
      IV, University of Munich, Munich, Germany.
FAU - Muller-Ladner, Ulf
AU  - Muller-Ladner U
AD  - Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, 
      Justus-Liebig-University Giessen, Bad Nauheim, Germany.
FAU - Specker, Christof
AU  - Specker C
AUID- ORCID: 0000-0003-2504-3229
AD  - Department of Rheumatology and Clinical Immunology, Kliniken Essen-Mitte, Essen, 
      Germany.
CN  - COVID-19 Task Force of the German Society for Rheumatology (DGRh)
LA  - eng
PT  - Journal Article
DEP - 20210908
PL  - Germany
TA  - Rheumatol Int
JT  - Rheumatology international
JID - 8206885
RN  - 0 (COVID-19 Vaccines)
SB  - IM
MH  - Adult
MH  - Aged
MH  - *Attitude of Health Personnel
MH  - COVID-19 Vaccines/*immunology
MH  - Cross-Sectional Studies
MH  - Female
MH  - Germany
MH  - *Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Rheumatic Diseases/drug therapy
MH  - Rheumatologists/*psychology
MH  - Rheumatology/methods
MH  - Surveys and Questionnaires
PMC - PMC8425463
OTO - NOTNLM
OT  - COVID-19 vaccines
OT  - Glucocorticoids
OT  - Immunmodulatory drugs
OT  - Inflammatory rheumatic diseases
OT  - Rituximab
COIS- The other authors declared no competing interests.
FIR - Hoyer, Bimba
IR  - Hoyer B
FIR - Lorenz, Hanns-Martin
IR  - Lorenz HM
FIR - Regierer, Anne
IR  - Regierer A
FIR - Richter, Jutta
IR  - Richter J
FIR - Schmeiser, Tim
IR  - Schmeiser T
FIR - Strangfeld, Anja
IR  - Strangfeld A
FIR - Voll, Reinhard
IR  - Voll R
FIR - Voormann, Anna
IR  - Voormann A
EDAT- 2021/09/10 06:00
MHDA- 2021/10/21 06:00
PMCR- 2021/09/08
CRDT- 2021/09/09 06:59
PHST- 2021/06/29 00:00 [received]
PHST- 2021/08/30 00:00 [accepted]
PHST- 2021/09/10 06:00 [pubmed]
PHST- 2021/10/21 06:00 [medline]
PHST- 2021/09/09 06:59 [entrez]
PHST- 2021/09/08 00:00 [pmc-release]
AID - 10.1007/s00296-021-04986-1 [pii]
AID - 4986 [pii]
AID - 10.1007/s00296-021-04986-1 [doi]
PST - ppublish
SO  - Rheumatol Int. 2021 Nov;41(11):1949-1956. doi: 10.1007/s00296-021-04986-1. Epub 
      2021 Sep 8.